Hodgkin's Lymphoma

Positron Emission Tomography Provides Accurate Staging Data

Published in Blood Weekly, March 22nd, 2001

by Michael Greer, staff medical writer -- Oncologists say that positron emission tomography can provide valuable and perhaps life-saving information about patients with Hodgkin's lymphoma.

"¹⁸F-fluorodeoxyglucose positron emission tomography (¹⁸F-FDG PET) offers the advantage of metabolic imaging that is largely independent of morphologic criteria," noted Guy Jerusalem and colleagues in Belgium.

Jerusalem et al. found that ¹⁸F-FDG PET compared very favorably to conventional imaging methods, including chest X-rays and computed tomography (CT) scans.

¹⁸F-FDG PET had a sensitivity of 91%...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2001-03-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry